Evidence map›Paper›PMID 37430076›Full record

ArticleNature biotechnology2024

Whole-body cellular mapping in mouse using standard IgG antibodies.

Hongcheng Mai, Jie Luo, Luciano Hoeher, Rami Al-Maskari, Izabela Horvath, Ying Chen, Florian Kofler, Marie Piraud, Johannes C Paetzold, Jennifer Modamio and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Nature biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
38.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 109 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. EpiBrain: the brain's epigenetic landscape in a snapshot.bioRxiv : the preprint server for biology · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Hongcheng Mai *Institute for Tissue Engineering and Regenerative Medicine, Helmholtz Center Munich, Neuherberg, Germany.
Jie Luo *Institute for Tissue Engineering and Regenerative Medicine, Helmholtz Center Munich, Neuherberg, Germany.
Luciano HoeherInstitute for Tissue Engineering and Regenerative Medicine, Helmholtz Center Munich, Neuherberg, Germany.
Rami Al-MaskariInstitute for Tissue Engineering and Regenerative Medicine, Helmholtz Center Munich, Neuherberg, Germany.
Izabela HorvathInstitute for Tissue Engineering and Regenerative Medicine, Helmholtz Center Munich, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-1702-2869
Ying ChenInstitute for Tissue Engineering and Regenerative Medicine, Helmholtz Center Munich, Neuherberg, Germany.
Florian KoflerHelmholtz Al, Helmholtz Center Munich, Neuherberg, Germany.
Marie PiraudHelmholtz Al, Helmholtz Center Munich, Neuherberg, Germany.
Johannes C PaetzoldInstitute for Tissue Engineering and Regenerative Medicine, Helmholtz Center Munich, Neuherberg, Germany.
Jennifer ModamioInstitute for Tissue Engineering and Regenerative Medicine, Helmholtz Center Munich, Neuherberg, Germany.
Mihail TodorovInstitute for Tissue Engineering and Regenerative Medicine, Helmholtz Center Munich, Neuherberg, Germany.
Markus ElsnerInstitute for Tissue Engineering and Regenerative Medicine, Helmholtz Center Munich, Neuherberg, Germany.ORCID http://orcid.org/0000-0001-7227-5212
Farida HellalInstitute for Tissue Engineering and Regenerative Medicine, Helmholtz Center Munich, Neuherberg, Germany.
Ali ErtürkInstitute for Tissue Engineering and Regenerative Medicine, Helmholtz Center Munich, Neuherberg, Germany. ali.erturk@helmholtz-munich.de.ORCID http://orcid.org/0000-0001-5163-5100
Helmholtz Zentrum München · DETUM Klinikum · DE

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01KX2121Deutsche Forschungsgemeinschaft (German Research Foundation) EXC 2145 SyNergy, ID 390857198Deutsche Forschungsgemeinschaft (German Research Foundation) SFB 1052, project A9; TR 296 project 03
6 · The paper itself

Abstract

Whole-body imaging techniques play a vital role in exploring the interplay of physiological systems in maintaining health and driving disease. We introduce wildDISCO, a new approach for whole-body immunolabeling, optical clearing and imaging in mice, circumventing the need for transgenic reporter animals or nanobody labeling and so overcoming existing technical limitations. We identified heptakis(2,6-di-O-methyl)-β-cyclodextrin as a potent enhancer of cholesterol extraction and membrane permeabilization, enabling deep, homogeneous penetration of standard antibodies without aggregation. WildDISCO facilitates imaging of peripheral nervous systems, lymphatic vessels and immune cells in whole mice at cellular resolution by labeling diverse endogenous proteins. Additionally, we examined rare proliferating cells and the effects of biological perturbations, as demonstrated in germ-free mice. We applied wildDISCO to map tertiary lymphoid structures in the context of breast cancer, considering both primary tumor and metastases throughout the mouse body. An atlas of high-resolution images showcasing mouse nervous, lymphatic and vascular systems is accessible at http://discotechnologies.org/wildDISCO/atlas/index.php .

Indexed as

Imaging, Three-DimensionalImmunoglobulin GAnimalsMiceImmunoglobulin G

Identifiers

PMID37430076
PMCPMC11021200
OpenAlexW4383868313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.